Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1

Status

Completed 16Unknown 9Terminated 6Active not recruiting 5Recruiting 4Not yet recruiting 3

Sponsor Class

OTHER 6NETWORK 3NIH 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 3Genitourinary 2Tumor-Agnostic 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × OTHER × Denosumab × Clear all
NCT03408652 2021-10-22

MOSCAR

Centre Leon Berard

Phase 3 Terminated
1 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT01545648 2020-01-02

Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer

University of California, San Francisco

Phase 2 Terminated
4 enrolled 7 charts
Tumor-Agnostic

Neoplasms

NCT01952054 2019-11-22

Denosumab for Breast Cancer With Bone Mets

M.D. Anderson Cancer Center

Phase 2 Terminated
7 enrolled 8 charts
Breast

Breast Neoplasms

NCT02758132 2019-11-08

Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases

University of Hawaii

Phase 2 Terminated
1 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT01864798 2018-11-27

D-Beyond

Jules Bordet Institute

Phase 2 Terminated
27 enrolled
Breast

Breast Neoplasms

NCT03070002 2018-11-20

Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells

Northwestern University

Phase 2 Terminated
1 enrolled 6 charts
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡